Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guillermo Bastida

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Gastroenterologia Y Hepatologia|April 6, 2020
Recommendations by the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the treatment of patients with inflammatory bowel disease associated with spondyloarthritisYago González-Lama, Jesús Sanz, Guillermo Bastida, et al.
The American Journal of Gastroenterology|February 10, 2016
Impact of Smoking Cessation on the Clinical Course of Crohn's Disease Under Current Therapeutic Algorithms: A Multicenter Prospective StudyTiago Nunes, Maria Josefina Etchevers, Valle García-Sánchez, et al.
Scandinavian Journal of Gastroenterology|November 7, 2023
Real-world long-term effectiveness of ustekinumab in ulcerative colitis: results from a spanish open-label cohortMarisa Iborra, Rocio Ferreiro-Iglesias, Martín-Arranz Maria Dolores, et al.
BMJ Open Gastroenterology|April 28, 2020
Impact of comorbidities on anti-TNFα response and relapse in patients with inflammatory bowel disease: the VERNE studyIgnacio Marin-Jimenez, Guillermo Bastida, Ana Forés, et al.
Inflammatory Bowel Diseases|February 2, 2021
Re-induction With Intravenous Ustekinumab in Patients With Crohn's Disease and a Loss of Response to This TherapyFernando Bermejo, Laura Jiménez, Alicia Algaba, et al.
Inflammatory Bowel Diseases|April 3, 2012
Does smoking influence Crohn's disease in the biologic era? The TABACROHN studyTiago Nunes, Maria Josefina Etchevers, Olga Merino, et al.
Journal of Crohn'S & Colitis|May 26, 2012
High smoking cessation rate in Crohn's disease patients after physician advice--the TABACROHN StudyTiago Nunes, Maria Josefina Etchevers, Olga Merino, et al.
Digestive Diseases and Sciences|June 6, 2015
Infliximab Dose Escalation as an Effective Strategy for Managing Secondary Loss of Response in Ulcerative ColitisCarlos Taxonera, Manuel Barreiro-de Acosta, Marta Calvo, et al.
Journal of Crohn'S & Colitis|January 21, 2016
Outcomes of Medical and Surgical Therapy for Entero-urinary Fistulas in Crohn's DiseaseCarlos Taxonera, Manuel Barreiro-de-Acosta, Guillermo Bastida, et al.
Digestive Diseases (Basel, Switzerland)|August 23, 2023
The Risk of Developing Disabling Crohn's Disease: Validation of a Clinical Prediction Rule to Improve Treatment Decision MakingGuillermo Bastida Paz, Olga Merino Ochoa, Mariam Aguas Peris, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Gastroenterologia Y Hepatologia|April 6, 2020
Recommendations by the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on the treatment of patients with inflammatory bowel disease associated with spondyloarthritisYago González-Lama, Jesús Sanz, Guillermo Bastida, et al.
The American Journal of Gastroenterology|February 10, 2016
Impact of Smoking Cessation on the Clinical Course of Crohn's Disease Under Current Therapeutic Algorithms: A Multicenter Prospective StudyTiago Nunes, Maria Josefina Etchevers, Valle García-Sánchez, et al.
Scandinavian Journal of Gastroenterology|November 7, 2023
Real-world long-term effectiveness of ustekinumab in ulcerative colitis: results from a spanish open-label cohortMarisa Iborra, Rocio Ferreiro-Iglesias, Martín-Arranz Maria Dolores, et al.
BMJ Open Gastroenterology|April 28, 2020
Impact of comorbidities on anti-TNFα response and relapse in patients with inflammatory bowel disease: the VERNE studyIgnacio Marin-Jimenez, Guillermo Bastida, Ana Forés, et al.
Inflammatory Bowel Diseases|February 2, 2021
Re-induction With Intravenous Ustekinumab in Patients With Crohn's Disease and a Loss of Response to This TherapyFernando Bermejo, Laura Jiménez, Alicia Algaba, et al.
Inflammatory Bowel Diseases|April 3, 2012
Does smoking influence Crohn's disease in the biologic era? The TABACROHN studyTiago Nunes, Maria Josefina Etchevers, Olga Merino, et al.
Journal of Crohn'S & Colitis|May 26, 2012
High smoking cessation rate in Crohn's disease patients after physician advice--the TABACROHN StudyTiago Nunes, Maria Josefina Etchevers, Olga Merino, et al.
Digestive Diseases and Sciences|June 6, 2015
Infliximab Dose Escalation as an Effective Strategy for Managing Secondary Loss of Response in Ulcerative ColitisCarlos Taxonera, Manuel Barreiro-de Acosta, Marta Calvo, et al.
Journal of Crohn'S & Colitis|January 21, 2016
Outcomes of Medical and Surgical Therapy for Entero-urinary Fistulas in Crohn's DiseaseCarlos Taxonera, Manuel Barreiro-de-Acosta, Guillermo Bastida, et al.
Digestive Diseases (Basel, Switzerland)|August 23, 2023
The Risk of Developing Disabling Crohn's Disease: Validation of a Clinical Prediction Rule to Improve Treatment Decision MakingGuillermo Bastida Paz, Olga Merino Ochoa, Mariam Aguas Peris, et al.
Pageof 6